Sleep disorders in Parkinson's disease: Many causes, few therapeutic options

Journal of the Neurological Sciences

Volumn 314, Issue 1-2, 2012, Pages 12-19

  Diederich, Nico J ^a,b   McIntyre, Deborah J ^a  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Non motor symptoms; Parkinson's disease; RBD; Sleep disturbances

Indexed keywords

CLONAZEPAM; ESZOPICLONE; MELATONIN; MEMANTINE; OXYBATE SODIUM; QUETIAPINE;

AKINESIA; BEHAVIOR DISORDER; CLINICAL FEATURE; DISEASE PREDISPOSITION; DOPAMINERGIC ACTIVITY; HUMAN; HYPERSOMNIA; INSOMNIA; LOCUS CERULEUS; MAGNOCELLULAR NUCLEUS; MUSCLE ATONIA; PARASOMNIA; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PHENOTYPE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REM SLEEP; REVIEW; SLEEP DISORDER; SLEEP QUALITY; SYMPTOM;

AZABICYCLO COMPOUNDS; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; HYPNOTICS AND SEDATIVES; PARKINSON DISEASE; PIPERAZINES; POLYSOMNOGRAPHY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REM SLEEP BEHAVIOR DISORDER; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP, REM; SYNUCLEINS;

EID: 84857050285     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.10.025     Document Type: Review

References (100)

1. J. Parkinson An essay on the shaking palsy 1817 Sherwood, Neely, and Jones London
2. A.J. Hughes, S.E. Daniel, L. Kilford, and A.J. Lees Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 1992 181 184
3. I. Arnulf, E. Konofal, M. Merino-Andreu, J.L. Houeto, V. Mesnage, and M.L. Welter Parkinson's disease and sleepiness: an integral part of PD Neurology 58 2002 1019 1024
4. P. Martinez-Martin, C. Rodriguez-Blazquez, M.M. Kurtis, K.R. Chaudhuri NMSS ValidationGroup The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease Mov Disord 26 2011 399 406
5. R.B. Postuma, J.F. Gagnon, M. Vendette, M.L. Fantini, J. Massicotte-Marquez, and J. Montplaisir Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder Neurology 72 2009 1296 1300
6. K.R. Chaudhuri, S. Pal, A. DiMarco, C. Whately-Smith, K. Bridgman, and R. Mathew The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease J Neurol Neurosurg Psychiatry 73 2002 629 635
7. C. Trenkwalder, R. Kohnen, B. Högl, V. Metta, F. Sixel-Döring, and B. Frauscher Parkinson's disease sleep scale-validation of the revised version PDSS-2 Mov Disord 26 4 2011 Mar 644 652 10.1002/mds.23476. Epub 2011 Feb 10
8. E. Tandberg, J.P. Larsen, and K. Karlsen Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study Mov Disord 14 1999 922 927
9. A.J. Lees, N.A. Blackburn, and V.L. Campbell The nighttime problems of Parkinson's disease Clin Neuropharm 11 1988 512 519
10. J.J. van Hilten, M. Weggeman, E.A. van der Velde, G.A. Kerkhof, J.G. van Dijk, and R.A. Roos Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease J Neural Transm (P-D Sect) 5 1993 235 244
11. A.G. Beiske, J.H. Loge, M.J. Hjermstad, and E. Svensson Fatigue in Parkinson's disease: prevalence and associated factors Mov Disord 25 2010 2456 2460
12. O. Riedel, J. Klotsche, A. Spottke, G. Deuschl, H. Förstl, and F. Henn Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease J Neurol 257 2010 1073 1082
13. P. Barone, A. Antonini, C. Colosimo, R. Marconi, L. Morgante, and T.P. Avarello The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease Mov Disord 24 2009 1641 1649
14. K. Stavitsky, J.L. Saurman, and P. McNamara Cronin-Golomb ASLEEP in Parkinson's disease: a comparison of actigraphy and subjective measures Parkinsonism Relat Disord 16 2010 280 283
15. D.B. Rye The two faces of Eve: dopamine's modulation of wakefulness and sleep Neurology 63 Suppl 3 2004 S2 S7
16. D.B. Rye, D.L. Bliwise, B. Dihenia, and P. Gurecki Daytime sleepiness in Parkinson's disease J Sleep Res 9 2000 63 69
17. N.J. Diederich, M. Vaillant, G. Mancuso, P. Lyen, and J. Tiete Progressive sleep 'destructuring' in Parkinson's disease. A polysomnographic study in 46 patients Sleep Med 6 2005 313 318
18. C. Pacchetti, E. Martignoni, M. Terzaghi, R. Zangaglia, F. Mancini, and G. Nappi Sleep attacks in Parkinson's disease: a clinical and polysomnographic study Neurol Sci 24 2003 195 196
19. L.M. Trotti, and D.B. Rye Neurobiology of sleep: the role of dopamine in Parkinson's disease K.R. Chaudruri, E. Tolosa, A. Schapira, W. Poewe, Non-motor symptoms in Parkinson's disease 2009 Oxford University Press 165 176
20. X. Drouot, S. Moutereau, J.P. Nguyen, J.P. Nguyen, J.P. Lefaucheur, and A. Créange Low levels of ventricular CSF orexin/hypocretin in advanced PD Neurology 61 2003 540 543
21. K. Yasui, Y. Inoue, T. Kanbayashi, T. Nomura, M. Kusumi, and K. Nakashima CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration J Neurol Sci 250 2006 120 123
22. Y. Compta, J. Santamaria, L. Ratti, E. Tolosa, A. Iranzo, and E. Muñoz Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia Brain 132 2009 3308 3317
23. T.C. Thannickal, Y.Y. Lai, and J.M. Siegel Hypocretin (orexin) cell loss in Parkinson's disease Brain 130 2007 1586 1595
24. R. Fronczek, S. Overeem, S.Y. Lee, I.M. Hegeman, J. van Pelt, and S.G. van Duinen Hypocretin (orexin) loss in Parkinson's disease Brain 130 2007 1577 1585
25. I.Z. Haq, Y. Naidu, P. Reddy, and K.R. Chaudhuri Narcolepsy in Parkinson's disease Expert Rev Neurother 10 2010 879 884
26. H. Braak, K. Del Tredici, U. Rüb, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211
27. I. Arnulf, M. Ferraye, V. Fraix, A.L. Benabid, S. Chabardès, and L. Goetz Sleep induced by stimulation in the human pedunculopontine nucleus area Ann Neurol 67 2010 546 549
28. S. Alessandro, R. Ceravolo, and L. Brusa Non-motor functions in Parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains J Neurol Sci 289 2010 44 48
29. A.W. Amara, R.L. Watts, and H.C. Walker The effects of deep brain stimulation on sleep in Parkinson's disease Ther Adv Neurol Disord 4 2011 15 24
30. C.L. Comella, T.M. Nardine, N.J. Diederich, and G.T. Stebbins Sleep- related violence, injury, and REM sleep behavior disorder in Parkinson's disease Neurology 51 1998 526 529
31. J.F. Gagnon, M.A. Bédard, M.L. Fantini, D. Petit, M. Panisset, and S. Rompré REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease Neurology 59 2002 585 589
32. D.L. Bliwise, L.M. Trotti, S.A. Greer, J.J. Juncos, and D.B. Rye Phasic muscle activity in sleep and clinical features of Parkinson disease Ann Neurol 68 2010 353 359
33. S. Lavault, S. Leu-Semenescu, S. Tezenas du Montcel, V. Cochen de Cock, and M. Vidailhet Arnulf I. Does clinical rapid eye movement behavior disorder predict worse outcomes in Parkinson's disease J Neurol 257 2010 1154 1159
34. C.H. Schenck, S.R. Bundlie, M.G. Ettinger, and M.W. Mahowald Chronic behavioral disorders of human REM sleep: a new category of parasomnia Sleep 9 1986 293 308
35. American Academy of Sleep Medicine International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual 2001 American Academy of Sleep Medicine Chicago, Illinois 97
36. C.H. Schenck, S.A. Lee, M.A. Bornemann, and M.W. Mahowald Potentially lethal behaviors associated with rapid eye movement sleep behavior disorder: review of the literature and forensic implications J Forensic Sci 54 2009 1475 1484
37. V.C. De Cock, M. Vidailhet, S. Leu, A. Texeira, E. Apartis, and A. Elbaz Restoration of normal motor control in Parkinson's disease during REM sleep Brain 130 2007 450 456
38. V.C. De Cock, R. Debs, and D. Oudiette The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy Brain 134 2011 856 862
39. O. Lapierre, and J. Montplaisir Polysomnographic features of REM sleep behavior disorder: development of a scoring method Neurology 42 1992 1371 1374
40. J. Montplaisir, J.F. Gagnon, M.L. Fantini, R.B. Postuma, Y. Dauvilliers, and A. Desautels Polysomnographic diagnosis of idiopathic REM sleep behavior disorder Mov Disord 25 2010 2044 2051
41. B.F. Boeve, M.H. Silber, C.B. Saper, T.J. Ferman, D.W. Dickson, and J.E. Parisi Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease Brain 130 2007 2770 2788
42. M.M. Unger, M. Belke, K. Menzler, J.T. Heverhagen, B. Keil, and K. Stiasny-Kolster Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantianigra, olfactory region, and other brain regions Sleep 33 2010 767 773
43. C.H. Schenck, S.R. Bundlie, and M.W. Mahowald Delayed emergence of a Parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder Neurology 46 1996 388 393
44. A. Iranzo, J.L. Molinuevo, J. Santamaría, M. Serradell, M.J. Martí, and F. Valldeoriola Rapid eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study Lancet Neurol 5 2006 572 577
45. J.F. Gagnon, R.B. Postuma, S. Mazza, J. Doyon, and J. Montplaisir Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases Lancet Neurol 5 2006 424 432
46. D.O. Claassen, K.A. Josephs, J.E. Ahlskog, M.H. Silber, M. Tippmann-Peikert, and B.F. Boeve REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century Neurology 75 2010 494 499
47. R.B. Postuma, J.F. Gagnon, S. Rompré, and J.Y. Montplaisir Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease Neurology 74 2010 239 244
48. R.B. Postuma, A.E. Lang, J. Massicotte-Marquez, and J. Montplaisir Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder Neurology 66 2006 845 851
49. R.B. Postuma, J.F. Gagnon, M. Vendette, and J.Y. Montplaisir Idiopathic REM sleep behavior disorder in the transition to degenerative disease Mov Disord 24 2009 2225 2232
50. J.F. Gagnon, M. Vendette, R.B. Postuma, C. Desjardins, J. Massicotte-Marquez, and M. Panisset Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease Ann Neurol 66 2009 39 47
51. P.A. Lanfranchi, L. Fradette, J.F. Gagnon, R. Colombo, and J. Montplaisir Cardiac autonomic regulation during sleep in idiopathic REM sleep behavior disorder Sleep 30 2007 1019 1025
52. T. Miyamoto, M. Miyamoto, Y. Inoue, Y. Usui, K. Suzuki, and K. Hirata Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder Neurology 67 2006 2236 2238
53. B.F. Boeve REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions Ann N Y Acad Sci 1184 2010 15 54
54. I. Arnulf, and S. Leu-Semenescu Sleepiness in Parkinson's disease Parkinsonism Relat Disord 15 Suppl 3 2009 S101 S104
55. M.M. Ohayon From wakefulness to excessive sleepiness: what we know and still need to know Sleep Med Rev 12 2008 129 141
56. S. Frucht, J.D. Rogers, P.E. Greene, M.F. Gordon, and S. Fahn Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole Neurology 52 1999 1908 1910
57. D.E. Hobson, A.E. Lang, W.R. Martin, A. Razmy, J. Rivest, and J. Fleming Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group JAMA 287 2002 455 463
58. S. Paus, H.M. Brecht, J. Köster, G. Seeger, T. Klockgether, and U. Wüllner Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease Mov Disord 18 2003 659 667
59. P.O. Valko, D. Waldvogel, M. Weller, C.L. Bassetti, U. Held, and C.R. Baumann Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment Eur J Neurol 17 2010 1428 1436
60. E. Havlikova, J.P. van Dijk, J. Rosenberger, I. Nagyova, B. Middel, and T. Dubayova Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep J Neurol Sci 270 2008 107 113
61. B.M. Kluger, and J.H. Friedman Fatigue in Parkinson's disease K.R. Chaudruri, E. Tolosa, A. Schapira, W. Poewe, Non-motor symptoms in Parkinson's disease 2009 Oxford University Press 135 145
62. M. Politis, K. Wu, and S. Molloy Parkinson's disease symptoms: the patient's perspective Mov Disord 25 2010 1646 1651
63. Diederich, and C.L. Comella Sleep disturbances in Parkinson's disease Chokroverty Sleep and Movement Disorders 2003 Elsevier Amsterdam S.478 S.488
64. D. Kaynak, G. Kiziltan, H. Kaynak, G. Benbir, and O. Uysal Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment Eur J Neurol 12 2005 199 207
65. N.J. Diederich, V. Paolini, and M. Vaillant Slow wave sleep and dopaminergic treatment in Parkinson's disease.A polysomnographic study Acta Scand Neurol 120 2009 308 313
66. S. Wailke, J. Herzog, K. Witt, G. Deuschl, and J. Volkmann Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease Eur J Neurol 18 2011 590 596
67. N.J. Diederich, M. Vaillant, M. Leischen, G. Mancuso, S. Golinval, and R. Nati Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients Mov Disord 20 2005 1413 1418
68. V. Cochen De Cock, M. Abouda, S. Leu, D. Oudiette, E. Roze, and M. Vidailhet Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med 11 2010 247 252
69. L.M. Trotti, and D.L. Bliwise No increased risk of obstructive sleep apnea in Parkinson's disease Mov Disord 25 2010 2246 2249
70. D. Verbaan, S.M. van Rooden, J.J. van Hilten, and R.M. Rijsman Prevalence and clinical profile of restless legs syndrome in Parkinson's disease Mov Disord 25 2010 2142 2147
71. J.C. Möller, M. Unger, K. Stiasny-Kolster, and W.H. Oertel Restless Legs Syndrome (RLS) and Parkinson's disease (PD)-related disorders or different entities? J Neurol Sci 289 2010 135 137
72. P.A. Nausieda Sleep in Parkinson'S disease W.C. Koller, Handbook of Parkinson's disease 2nd edition 1993 M Dekker 451 467
73. T.A. Zesiewicz, K.L. Sullivan, I. Arnulf, K.R. Chaudhuri, J.C. Morgan, and G.S. Gronseth Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: treatment of nonmotor symptoms of Parkinson's disease. Report of the quality Standards Subcommittee of the American Academy of Neurology Neurology 74 2010 924 931
74. T.I. Morgenthaler, V.K. Kapur, T. Brown, T.J. Swick, C. Alessi, and R.N. Aurora Friedman L, Maganti R, Owens J, Pancer J, Zak R; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin Sleep 30 2007 1705 1711
75. K.R. Chaudhuri, and A.H.V. Schapira Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment Lancet Neurol 8 2009 464 474
76. M. Menza, R.D. Dobkin, H. Marin, and K. Bienfait Sleep disturbances in Parkinson's disease Mov Disord 25 Suppl 1 2010 S117 S122
77. M. Menza, R.D. Dobkin, and H. Marin Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo Mov Disord 25 2010 1708 1714
78. R.N. Aurora, R.S. Zak, R.K. Maganti, and S.H. Auerbach Best practice guide for the treatment of REM sleep behavior disorder (RBD) J Clin Sleep Med 6 2010 85 95
79. P. Barone Treatment of depressive symptoms in Parkinson's disease Eur J Neurol Suppl 1 2011 11 15
80. P. Skapinakis, E. Bakola, G. Salanti, G. Lewis, A.P. Kyritsis, and V. Mavreas Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials BMC Neurol 10 Jun 21 2010 49
81. M.R. Lemke Dopamine agonists in the treatment of non-motor symptoms of Parkinson's disease: depression Eur J Neurol 15 Suppl 2 2008 9 14
82. C. Trenkwalder, B. Kies, and M. Rudzinska Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER) Mov Disord 26 2011 90 99
83. K.R. Chaudhuri, P. Martinez-Martin, K.A. Rolfe, J. Cooper, C.B. Rockett, and L. Giorgi Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease Eur J Neurol Jun 23 2011 10.1111/j.1468-1331.2011.03442.x [Epub ahead of print]
84. P. Dusek, J. Busková, E. Růzicka, V. Majerová, A. Srp, and R. Jech Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson's disease Clin Neuropharmacol 33 2010 186 190
85. V. Larsson, D. Aarsland, C. Ballard, L. Minthon, and E. Londos The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia Int J Geriatr Psychiatry 25 2010 1030 1038
86. C. Juri, P. Chaná, J. Tapia, C. Kunstmann, and T. Parrao Quetiapine for insomnia in Parkinson disease: results from an open-label trial Clin Neuropharmacol 28 2005 185 187
87. C.A. Medeiros Carvalhedo de Bruin PF, Lopes LA, Magalhães MC, de Lourdes Seabra M, de Bruin VM. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease.A randomized, double blind, placebo-controlled study J Neurol 254 2007 459 464
88. D. Garfinkel, M. Laudon, D. Nof, and N. Zisapel Improvement of sleep quality in elderly people by controlled-release melatonin Lancet 346 1995 541 544
89. A.G. Wade, I. Ford, G. Crawford, A.D. McMahon, T. Nir, and M. Laudon Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes Curr Med Res Opin 23 2007 2597 2605
90. A. Wade, and S. Downie Prolonged-release melatonin for the treatment of insomnia in patients over 55 years Expert Opin Investig Drugs 17 2008 1567 1572
91. A.G. Wade, G. Crawford, I. Ford, A. McConnachie, T. Nir, and M. Laudon Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response Curr Med Res Opin 27 2011 87 98
92. G.L. Willis Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process Rev Neurosci 19 2008 245 316
93. S. Paus, T. Schmitz-Hübsch, U. Wüllner, A. Vogel, T. Klockgether, and M. Abele Bright light therapy in Parkinson's disease: a pilot study Mov Disord 22 2007 1495 1498
94. G.L. Willis, and E.J. Turner Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study Chronobiol Int 24 2007 521 537
95. Y. Dauvilliers Insomnia in patients with neurodegenerative conditions Sleep Med Suppl 4 2007 S27 S34
96. K.E. Lyons, J.H. Friedman, N. Hermanowicz, S.H. Isaacson, R.A. Hauser, and B.P. Hersh Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects Clin Neuropharmacol 33 2010 5 10
97. W.G. Ondo, T. Perkins, T. Swick, K.L. Hull Jr., J.E. Jimenez, and T.S. Garris Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study Arch Neurol 65 2008 1337 1340
98. D. Kunz, and R. Mahlberg A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder J Sleep Res 19 2010 591 596
99. H. Kumru, A. Iranzo, E. Carrasco, F. Valldeoriola, M.J. Marti, and J. Santamaria Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease Sleep 31 2008 1418 1421
100. M.L. Fantini, J.F. Gagnon, and D. Filipini MontplaisirJ. The effects of pramipexole in REM sleep behavior disorder Neurology 61 2003 1418 1420